ArticleAntonie van Leeuwenhoek2025
Impact of plant growth promoting rhizobacteria inoculation on growth and physiological traits of ginger in field conditions.
Article in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diversity, molecular identification and plant growth promoting potential of endophytic bacteria from plantain (Frontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant growth-promoting rhizobacteria (PGPR) are known to enhance the productivity, development, yield, and soil health of both medicinal and vegetable crops. The present investigation evaluated the influence of PGPR on the growth attributes and physiological parameters of ginger, alongside soil quality, under field conditions. Field trials were carried out over three consecutive years (2020 to 2022), with ginger being planted each March. The experiment included six treatments: five PGPR strains-Bacillus subtilis IGPEB 1, Bacillus pumilus IGPEB 2, Bacillus altitudinis IGPEB 8, Pseudomonas koreensis IGPEB 17, and Bacillus endophyticus IGPEB 33-applied individually, along with an uninoculated control. These treatments were arranged in a randomized block design with five replications. Among the strains, B. endophyticus IGPEB 33 notably improved ginger's morphological traits, including shoot length, leaf number, leaf length, leaf width, and overall yield, compared to the control. This strain also significantly boosted the content of chlorophyll (a and b), total chlorophyll, and carotenoids in ginger leaves. Furthermore, B. endophyticus IGPEB 33 enhanced soil nitrogen content as well as catalase and urease enzymatic activity. Notably, urease activity was also increased with the inoculation of B. subtilis IGPEB 1, B. pumilus IGPEB 2, and P. koreensis IGPEB 17. A significant positive correlation was observed between phosphorus levels and physiological parameters such as relative water content, photosynthetic pigments, and soil enzymes. Overall, this study highlights the effectiveness of PGPR in improving ginger growth and productivity through favorable modulation of plant physiology and soil biochemical properties, offering a promising approach for sustainable crop management. The positive correlations observed between PGPR inoculation, physiological traits, and yield performance suggest that these bacterial strains actively contribute to nutrient uptake, water retention, and stress tolerance mechanisms in ginger. Furthermore, their use promotes a sustainable and environmentally friendly alternative to chemical fertilizers, aligning with global efforts to reduce agricultural dependency on synthetic inputs. Given their effectiveness and potential scalability, these PGPR strains are strong candidates for development into commercial biofertilizer formulations.
Indexed as
Identifiers
40892082What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.